CompanyDrug

Sunshine Guojian’s SSGJ-608 Hits Primary Endpoint in Psoriasis Study

CompanyDrug

Zelgen Biopharmaceuticals’ Donafenib Receives NMPA Approval for Thyroid Cancer

Company

Siemens Healthineers Q3 2022 Results Show Decline Amid COVID-19 Impact

R&D

Chinese Researchers Map Cancer Genomic Alterations in 10,000 Patients

CompanyDeals

Longwood Valley Medtech Partners with J&J MedTech on Digital Surgery Biosystem

CompanyDeals

Elite Pharma Raises RMB100m in Series B Financing for Drug Delivery Tech

CompanyDeals

WuXi ATU Licenses TESSA Technology to Janssen Biotech for AAV Production

CompanyDeals

Medlander Medical Technology’s IPO Raises RMB 1 billion on Shanghai’s STAR Board

CompanyDrug

InnoCare Pharma’s Orelabrutinib sNDA Accepted for Marginal Zone Lymphoma

CompanyDeals

TianShiWei Raises Tens of Millions in Series A for Medical Aesthetics Expansion

CompanyDeals

BeiGene Partners with Jilin Cancer Hospital for Cancer Drug Development

Policy / Regulatory

China Ramps Up Monitoring of Clinically Shortage Drugs Involving 109 Varieties